Literature DB >> 18459160

Kinetics of histone H2AX phosphorylation and Chk2 activation in A549 cells treated with topotecan and mitoxantrone in relation to the cell cycle phase.

Hong Zhao1, Frank Traganos, Zbigniew Darzynkiewicz.   

Abstract

The DNA topoisomerase I (topo1) inhibitor topotecan (TPT) and topo2 inhibitors doxorubicin, etoposide and mitoxantrone (MXT) are widely used antitumor drugs. They stabilize otherwise transient ("cleavable") complexes of topo1 or topo2 with DNA, respectively. Collisions of DNA replication forks (during replication) or progressing RNA polymerase molecules (during transcription) with these complexes convert them into double-strand DNA breaks (DSBs). Formation of DSBs triggers activation of ATM and phosphorylation of histone H2AX, the markers that have been used to correlate DNA damage with cell cycle phase or induction of apoptosis. In the present study we explored a relationship between H2AX phosphorylation and activation of checkpoint kinase 2 (Chk2) in human lung carcinoma A549 cells treated with TPT or with MXT. Activation of Chk2 was detected immunocytochemically using a phospho-specific (Thr68) Ab and measuring Chk2-Thr68(P)immunofluorescence (IF), concurrently with DNA content, by laser scanning cytometry. In the untreated cells, activated Chk2 was present predominantly in centrosomes. Upon treatment with TPT or MTX, the activated Chk2 presented itself in form of either minute or large IF foci in the cell's nucleoplasm. H2AX phosphorylation whether induced by TPT or MXT was rapid, with the maximal rate occurring during the initial 2 h and peaking at 2 h of treatment. TPT or MXT induced Chk2 activation occurred at a distinctly slower pace, peaking at 4 h. While TPT-induced H2AX phosphorylation and Chk2 activation were maximal in S-phase cells, Chk2 activation was also much pronounced in G(2)M cells; the least affected by TPT were G(1) cells. MTX-induced H2AX phosphorylation was maximal in G(1) cells while Chk2 activation was maximal in G(2)M and minimal in G(1) cells. The pattern of cell-cycle phase specific response to TPT or MXT by H2AX phosphorylation and Chk2 activation was different when measured either as integrated or maximal pixel of gammaH2AX or Chk2-Thr68(P) IF, the former reflecting total IF per nucleus the latter stressing the punctate (foci) character of expression of these phospho-modified proteins. (c) 2008 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459160     DOI: 10.1002/cyto.a.20574

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  23 in total

1.  Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide.

Authors:  Hong Zhao; Paulina Rybak; Jurek Dobrucki; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2011-12-02       Impact factor: 4.355

2.  DNA damage detected with gammaH2AX in endometrioid adenocarcinoma cell lines.

Authors:  Maki Ikeda; Akira Kurose; Eriko Takatori; Toru Sugiyama; Frank Traganos; Zbigniew Darzynkiewicz; Takashi Sawai
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

3.  Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump.

Authors:  Adam M Sonabend; R Morgan Stuart; Jonathan Yun; Ted Yanagihara; Hamed Mohajed; Steven Dashnaw; Samuel S Bruce; Truman Brown; Alex Romanov; Manu Sebastian; Fernando Arias-Mendoza; Emilia Bagiella; Peter Canoll; Jeffrey N Bruce
Journal:  Neuro Oncol       Date:  2011-07-12       Impact factor: 12.300

4.  Cell synchronization by inhibitors of DNA replication induces replication stress and DNA damage response: analysis by flow cytometry.

Authors:  Zbigniew Darzynkiewicz; H Dorota Halicka; Hong Zhao; Monika Podhorecka
Journal:  Methods Mol Biol       Date:  2011

Review 5.  Translational research in phase I trials.

Authors:  Angelica Fasolo; Cristiana Sessa
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

6.  Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.

Authors:  Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2008-10-06       Impact factor: 4.534

Review 7.  Analysis of individual molecular events of DNA damage response by flow- and image-assisted cytometry.

Authors:  Zbigniew Darzynkiewicz; Frank Traganos; Hong Zhao; H Dorota Halicka; Joanna Skommer; Donald Wlodkowic
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 8.  Laser scanning cytometry: principles and applications-an update.

Authors:  Piotr Pozarowski; Elena Holden; Zbigniew Darzynkiewicz
Journal:  Methods Mol Biol       Date:  2013

9.  Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.

Authors:  Randy S D'Amico; Justin A Neira; Jonathan Yun; Nikita G Alexiades; Matei Banu; Zachary K Englander; Benjamin C Kennedy; Timothy H Ung; Robert J Rothrock; Alexander Romanov; Xiaotao Guo; Binsheng Zhao; Adam M Sonabend; Peter Canoll; Jeffrey N Bruce
Journal:  J Neurosurg       Date:  2019-08-02       Impact factor: 5.115

Review 10.  Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.

Authors:  Zbigniew Darzynkiewicz; Frank Traganos; Donald Wlodkowic
Journal:  Eur J Pharmacol       Date:  2009-10-18       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.